Chengxi Pharmaceutical Factory Established
JumpCan Pharmaceutical's history traces back to Taixing Chengxi Pharmaceutical Factory, founded in 1967 — a legacy spanning 59 years.
Jichuan Pharmaceutical Group Established
Restructured from State-owned to Private Joint-Stock
First Entry into Top 100 Chinese Pharmaceutical Industrial Enterprises
Successfully Listed
Successfully listed on the Shanghai Stock Exchange, stock code: 600566.
Acquired Dongke Pharmaceutical, Established Pudilan Personal Care
Acquired and established Shaanxi Dongke Pharmaceutical Co., Ltd. and Jiangsu Pudilan Personal Care Co., Ltd. marking a solid step in capital M&A.
Partnership with TJ Biopharma
JumpCan entered into a strategic partnership valued at nearly RMB 2 billion, setting a new benchmark in recent years for similar transactions in China's biopharmaceutical market and the global pediatric pharmaceutical sector.
JumpCan reached a project collaboration valued at RMB 400 million, introducing an innovative oral PDE4 phosphodiesterase inhibitor and a targeted digestive protease inhibitor.
Culture Upgrade
Officially released the new purpose "Build a Joyful and Vibrant Life Together," simultaneously updating the six core values and behaviors.
Multiple Commercial Partnerships
JumpCan entered into partnerships with PrimeGene, Akeso, and Zedman Pharma for pumecitinib nasal spray, Yixining and Zelimei, respectively, marking continued progress in the commercialization of innovative medicines.